DYCLONE Drug Patent Profile
When do Dyclone patents expire, and when can generic versions of Dyclone launch?
Dyclone is a drug marketed by Astrazeneca and is included in one NDA.
The generic ingredient in DYCLONE is dyclonine hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the dyclonine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DYCLONE?
- What are the global sales for DYCLONE?
- What is Average Wholesale Price for DYCLONE?
Summary for DYCLONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| DailyMed Link: | DYCLONE at DailyMed |
US Patents and Regulatory Information for DYCLONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | DYCLONE | dyclonine hydrochloride | SOLUTION;TOPICAL | 009925-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | DYCLONE | dyclonine hydrochloride | SOLUTION;TOPICAL | 009925-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
